Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Effects of Lactate on Nutrient Absorption in Pre-Diabetes

Official title: Does Co-administration of Lactate Affect Postprandial Nutrient Absorption and Fat Disposition?

Run by University of Aarhus · NCT06668714 · Data updated 2026-11-12

This study is testing if taking lactate can help people with pre-diabetes absorb nutrients better and manage fat after meals.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment25 (estimated)
SponsorUniversity of Aarhus
Academic / other
Drugs / interventionsradiation
Locations1 site (Aarhus)
StatusRecruiting
StartedAugust 22, 2024
Main results expectedJanuary 2026
Study endsJanuary 2026
Registry record updatedJune 19, 2025
Trial IDNCT06668714 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 50 and older with pre-diabetes, as indicated by specific HbA1c levels.

Probably not a fit

Patients with conditions affecting blood glucose metabolism or those on certain medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how oral lactate administration influences nutrient absorption and fat utilization in individuals with pre-diabetes. The researchers hypothesize that lactate can improve post-meal fat metabolism by slowing gastric emptying and enhancing feelings of fullness. To measure these effects, a novel tracer method using a fluorine-labeled fatty acid analog combined with PET-CT imaging will be employed. The study aims to validate these effects in a Danish population, focusing on how lactate impacts fat partitioning during meals.

Why it matters

Potential benefit: If successful, this approach could lead to improved metabolic health and weight management for patients with pre-diabetes.

How similar studies have gone: While previous studies have shown promising results with lactate in other populations, this specific approach in pre-diabetes is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 50+ years
* Written and oral consent
* HbA1c 39-47 mmol/L

Exclusion Criteria:

* Medicine with an impact on blood glucose and glucose metabolism.
* Newly started medicine (\<3 months prior to the inclusion time)
* Medicine changes (\<3 months prior to the inclusion time and planned changes during the trial)
* Affected screening blood sample as evaluated by PI
* Hba1c \> 47
* Allergy to paracetamol
* Doesn't speak or understand Danish
* Special diets

The eight healthy individuals will be included by the same criteria except for not having pre-diabetes

Where it's running

  • Aarhus University Hospital
    Aarhus, Denmark
    Recruiting

Study contacts

  • Principal investigator: Esben Søndergaard — Aarhus University, Steno Diabetes Center Aarhus
  • Study coordinator: Natasa B Zubanovic, Medical Doctor
  • Email: natasa.bz@clin.au.dk
  • Phone: 004561698000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.